Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya
We performed a countrywide assessment of HIV drug resistance among 123 patients with virological failure on second-line antiretroviral therapy (ART) in Kenya. The percentage of patients harbouring intermediate-to-high-level resistance was 27% for lopinavir-ritonavir, 24% for atazanavir-ritonavir and...
Main Authors: | Inzaule, S, Hamers, R, Mukui, I, Were, K, Owiti, P, Kwaro, D, de Wit, T, Zeh, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
by: Harris Onywera, et al.
Published: (2017-01-01) -
When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children
by: Inzaule, S, et al.
Published: (2018) -
Incidence and predictors of first line antiretroviral regimen modification in western Kenya.
by: Seth Inzaule, et al.
Published: (2014-01-01) -
Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk
by: Inzaule, S, et al.
Published: (2016) -
Pan-resistant HIV-1: what's next?
by: Hamers, RL, et al.
Published: (2020)